The Recombinant DNA Technology Market size is expected to be worth around USD 1288.5 Bn by 2032 from USD 786.7 Bn in 2023, growing at a CAGR of 5.8% As scientific and technological advancements ...
A new study in the Journal of Interferon & Cytokine Research (JICR) showed that a specific retinoic acid-inducible gene I ...
A multi-national, multi-institutional study led by Weill Cornell Medicine investigators found little natural resistance to a ...
Vimkunya is supplied as an injectable suspension; the vaccine is administered intramuscularly as a single 0.8mL dose.
15 小时
MedPage Today on MSNWill the Egg Shortage Affect Flu Shots?Previous bird flu outbreaks and decades-old public health infrastructure have led industry to protect the hens used for ...
6 天
allAfrica.com on MSNUganda conducts first ever Ebola Sudan vaccine trialIt is also the first clinical trial of the vaccine during an outbreak Kampala, Uganda | AGENCIES | In a global first, ...
First chikungunya vaccine approved for persons as young as 12 years old, addressing an unmet need for chikungunya prevention for younger ...
Bird flu has now spread to humans in a dozen states after public health officials confirmed an Ohio man had contracted the ...
The influenza A virus genome consists of eight segments of single-stranded, negative-sense viral RNA, which encode multiple ...
A multi-national, multi-institutional study investigators found little natural resistance to a new HIV therapy called lenacapavir in a population of patients in Uganda.
19 小时
News Medical on MSNNew HIV therapy lenacapavir shows high efficacy in Ugandan populationA multi-national, multi-institutional study led by Weill Cornell Medicine investigators found little natural resistance to a ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果